Stocks
GlaxoSmithKline (GSK) OCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| OCF, £ | ? | 7 952 000 000 | 7 403 000 000 | 7 403 000 000 | 6 348 000 000 | 6 348 000 000 | 9 093 000 000 | ||
| Changes by years, y/y, % | 0% | -7% | 0% | -14% | 0% | -5.5% | |||
GlaxoSmithKline. OCF, £
GlaxoSmithKline. OCF, changes, %
GlaxoSmithKline. OCF, sum by quarters, £
GlaxoSmithKline (GSK) OCF US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| OCF, £ | ? | 1 307 000 000 | 2 212 000 000 | 2 971 000 000 | 2 971 000 000 | 939 000 000 | 9 093 000 000 | |
| Changes by years, y/y, % | -20% | +67% | +56% | +56% | +1 672% | |||
| Changes by quarters, q/q, % | 0% | +69% | +34% | 0% | -68% | |||
